QuidelOrtho to Participate in Upcoming Investor Conferences

Rhea-AI Summary

QuidelOrtho (Nasdaq: QDEL), a global provider of innovative in vitro diagnostic technologies, has announced its participation in two upcoming investor conferences:

1. Morgan Stanley 22nd Annual Global Health Conference in New York, NY on September 5, 2024. President and CEO Brian Blaser and CFO Joseph Busky will participate in a fireside chat at 7:00 a.m. ET.

2. 2024 Baird Global Healthcare Conference in New York, NY on September 10, 2024. Blaser and Busky will participate in a fireside chat at 9:40 a.m. ET.

Live webcasts and replays of both events will be accessible through the 'Events & Presentations' section of QuidelOrtho's Investor Relations webpage.

SAN DIEGO--(BUSINESS WIRE)-- QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team will attend two upcoming investor conferences.

Morgan Stanley 22^nd Annual Global Health Conference – New York, NY

On Thursday, September 5, 2024, QuidelOrtho’s President and Chief Executive Officer, Brian Blaser, and Chief Financial Officer, Joseph Busky, are scheduled to participate in a fireside chat at 7:00 a.m. ET / 4:00 a.m. PT.

2024 Baird Global Healthcare Conference – New York, NY

On Tuesday, September 10, 2024, Messrs. Blaser and Busky are scheduled to participate in a fireside chat at 9:40 a.m. ET / 6:40 a.m. PT.

Interested parties can access the live webcasts and replays of both events in the “Events & Presentations” section of the “Investor Relations” page of QuidelOrtho’s website at https://ir.quidelortho.com/.

About QuidelOrtho Corporation

QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.

Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence.

Building upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects and a more informed path is illuminated for each of us.

QuidelOrtho is advancing diagnostics to power a healthier future.

For more information, please visit www.quidelortho.com.

Source: QuidelOrtho Corporation

View source version on businesswire.com: https://www.businesswire.com/news/home/20240819953266/en/

Investor Contact:

Juliet Cunningham

Vice President, Investor Relations

IR@QuidelOrtho.com



Media Contact:

D. Nikki Wheeler

Senior Director, Corporate Communications

media@QuidelOrtho.com

Source: QuidelOrtho Corporation

FAQ

When is QuidelOrtho (QDEL) participating in the Morgan Stanley Global Health Conference?

QuidelOrtho (QDEL) is participating in the Morgan Stanley 22nd Annual Global Health Conference on Thursday, September 5, 2024, in New York, NY.

What time is QuidelOrtho's (QDEL) fireside chat at the Baird Global Healthcare Conference?

QuidelOrtho's (QDEL) fireside chat at the 2024 Baird Global Healthcare Conference is scheduled for 9:40 a.m. ET / 6:40 a.m. PT on Tuesday, September 10, 2024.

Who will represent QuidelOrtho (QDEL) at the upcoming investor conferences?

QuidelOrtho (QDEL) will be represented by President and CEO Brian Blaser and CFO Joseph Busky at both the Morgan Stanley and Baird investor conferences.

How can investors access the webcasts of QuidelOrtho's (QDEL) conference presentations?

Investors can access live webcasts and replays of QuidelOrtho's (QDEL) conference presentations through the 'Events & Presentations' section of the company's Investor Relations webpage at https://ir.quidelortho.com/.